Osteopenia Active Not Recruiting Phase 3 Trials for Risedronic acid (DB00884)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02186600Heartland Osteoporosis Prevention StudyTreatment